Effect of Plant-Derived n-3 Polyunsaturated Fatty Acids on Blood Lipids and Gut Microbiota: A Double-Blind Randomized Controlled Trial
Authors:
Open Access
- 11 February 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 9, 830960
Abstract
Background: Several cardioprotective mechanisms attributed to n-3 polyunsaturated fatty acids (PUFAs) have been widely documented. Significant interest has recently focused on the role of human gut microbiota in metabolic disorders. However, the role of plant-derived n-3 PUFAs on blood lipid profiles is controversial and the effect on gut microbiota is still unclear.Objectives: We aimed to perform a double-blind randomized controlled trial to test the effect of plant-derived n-3 PUFAs on the blood lipids and gut microbiota of patients with marginal hyperlipidemia.Methods: According to the inclusion and exclusion criteria, 75 participants with marginal hyperlipidemia were randomly assigned to the intervention group (supplied with n-3 PUFA-enriched plant oil) or control group (supplied with corn oil), respectively, for a 3-month treatment. Participants and assessors were blinded to the allocation. The primary outcomes of the trial were the changes in serum lipid levels. Secondary outcomes were changes in gut microbiota and metabolites. For the primary outcomes, we conducted both an intent-to-treat (ITT) analysis and a per protocol (PP) analysis. For the secondary outcomes, we only conducted the PP analysis among the participants who provided fecal sample.Results: Fifty-one participants completed the trial. Relative to the control group, the n-3 PUFA supplementation resulted in significant reduction in total cholesterol (TC) levels (−0.43 mmol/L, 95% CI−0.84 to−0.01 mmol/L, P < 0.05). The n-3 PUFA supplementation was also associated with significantly increased relative abundance of Bacteroidetes in phylum level (P < 0.01; false discovery rate (FDR) corrected p = 0.11), and decreased the ratio between Firmicutes and Bacteroidetes (P < 0.05; FDR corrected p = 0.16). At genus level, the intervention of plant derived n-3 PUFAs resulted in a significant decrease in relative abundance of Phascolarctobacterium (P < 0.01; FDR corrected p = 0.18) and Veillonella (P < 0.01; FDR corrected p = 0.18) after the intervention.Conclusions: Our results demonstrated that plant-derived n-3 PUFAs beneficially affected the serum levels of TC and decreased the ratio between Firmicutes and Bacteroidetes during the 12-week intervention period, which might confer advantageous consequences for lipid metabolism and intestinal health.Keywords
Funding Information
- National Natural Science Foundation of China
- National Key Research and Development Program of China
This publication has 63 references indexed in Scilit:
- Dietary Echium Oil Increases Long-Chain n–3 PUFAs, Including Docosapentaenoic Acid, in Blood Fractions and Alters Biochemical Markers for Cardiovascular Disease Independently of Age, Sex, and Metabolic SyndromeThe Journal of Nutrition, 2014
- Gut microbiome and metabolic diseasesSeminars in Immunopathology, 2013
- α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysisThe American Journal of Clinical Nutrition, 2012
- Using QIIME to Analyze 16S rRNA Gene Sequences from Microbial CommunitiesCurrent Protocols in Microbiology, 2012
- Using QIIME to Analyze 16S rRNA Gene Sequences from Microbial CommunitiesCurrent Protocols in Bioinformatics, 2011
- Search and clustering orders of magnitude faster than BLASTBioinformatics, 2010
- The Ribosomal Database Project: improved alignments and new tools for rRNA analysisNucleic Acids Research, 2008
- Association of Genetic Variations With Nonfatal Venous Thrombosis in Postmenopausal WomenJAMA, 2007
- Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic reviewAtherosclerosis, 2006
- Effect of α linolenic acid on cardiovascular risk markers: a systematic reviewHeart, 2005